Abstract
Cytoreductive surgery coupled with hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) is a part of the treatment of peritoneal carcinomatosis of colorectal origin, giving hope of prolonged survival. This treatment is becoming more codified, the latest results published highlight the decline in morbidity and mortality and the interest of using new drugs like oxaliplatin. Future efforts should therefore focus on homogenization and rationalization of the indications.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
